Technology
Health
Biotechnology

Eloxx Pharmaceuticals

$12.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.03 (-7.80%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ELOX and other stocks, options, ETFs, and crypto commission-free!

About

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Read More It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded on December 19, 2017 and is headquartered in Waltham, MA.

Employees
29
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
473.35M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
89.01K
High Today
$13.21
Low Today
$12.17
Open Price
$13.21
Volume
9.31K
52 Week High
$24.60
52 Week Low
$7.30

Collections

Technology
Health
Biotechnology
Medical
2018 IPO
US
North America

News

The Motley FoolMar 8

Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Q4 2018 Earnings Conference Call , 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning, everyone, and welcome to Eloxx Pharmaceuticals Fourth Quarter and Full-Year 2018 Earnings Webcast and Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Barbara Ryan, Eloxx's Investor Relations Officer. Please begin. Barbara Ryan -- Investor Relations O...

142
Seeking AlphaMar 8

Eloxx Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Eloxx Pharmaceuticals, Inc. in conjunction with their 2018 Q4 earnings call. 1 26 Click to enlarge Notes:...

61

Earnings

-$0.48
-$0.43
-$0.37
-$0.32
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
-$0.40 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.